Recent developments in Taiwan’s patent system, cross-border pharmaceutical licensing, and IP litigation demonstrate how intellectual property has become a critical business asset rather than merely a legal right. Companies that effectively integrate patent portfolio management, licensing strategies, and litigation risk assessment will be better positioned to compete in an increasingly innovation-driven and highly regulated global market.

Read more on  website.

深度研究｜庆辰法律事务所：专利审查的最新发展及其对企业的战略影响

#IntellectualProperty #PatentPortfolio #IPStrategy #PatentLitigation #LifeSciences #PharmaLicensing #Innovation #TechnologyCommercialization #Taiwan #BusinessGrowth